Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation
Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation
Aernoud Bavinck
1, 2
, MD ;
Saskia E M Schols
1, 3
, MD, PhD ;
Wilfred Teunissen
4
, MSc ;
Amy Shapiro
5
, MD ;
Nicole M A Blijlevens
1
, MD, PhD ;
Kyle Davis
5
, MD ;
Waander van Heerde
2, 3
, PhD
1
Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
2
Enzyre, Nijmegen, The Netherlands
3
Hemophilia Treatment Centre Nijmegen-Eindhoven-Maastricht, Nijmegen, The Netherlands
4
Panton, Deventer, The Netherlands
5
Department of Pediatric Hematology, Innovative Hematology, Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, United States